Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 18;8(7):69.
doi: 10.3390/cancers8070069.

Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer

Affiliations
Review

Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer

Elke Kaemmerer et al. Cancers (Basel). .

Abstract

The wingless (Wnt) signaling is suggested as a fundamental hierarchical pathway in regulation of proliferation and differentiation of cells. The Wnt ligands are small proteins of about 40 kDa essentially for regulation and initiation of the Wnt activity. They are secreted proteins requiring acylation for activity in the Wnt signaling cascade and for functional interactivity with transmembrane proteins. Dual lipidation is important for posttranslational activation of the overwhelming number of Wnt proteins and is probably involved in their spatial distribution. The intestinal mucosa, where Wnt signaling is essential in configuration and maintenance, is an established model to study Wnt proteins and their role in carcinogenesis and cancer. The intestinal crypt-villus/crypt-plateau axis, a cellular system with self-renewal, proliferation, and differentiation, is tightly coordinated by a Wnt gradient. In the review, some attention is given to Wnt3, Wnt3A, and Wnt2B as important members of the Wnt family to address the role of lipidation and modifiers of Wnt proteins in intestinal carcinogenesis. Wnt3 is an important player in establishing the Wnt gradient in intestinal crypts and is mainly produced by Paneth cells. Wnt2B is characterized as a mitochondrial protein and shuttles between mitochondria and the nucleus. Porcupine and ACSL5, a long-chain fatty acid activating enzyme, are introduced as modifiers of Wnts and as interesting strategy to targeting Wnt-driven carcinogenesis.

Keywords: Wnt; cancer; lipidation; modifier.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scheme of canonical wingless (Wnt) protein signaling. (Left) In the absence of activated Wnt phosphorylation of β-catenin protein by a protein-kinase complex is found resulting in degradation of β-catenin; (Right) After coupling of activated Wnt to Fzd the protein-kinase complex is translocated and accumulation of β-catenin is found. The active β-catenin protein translocates into the nucleus and activates gene transcription via T cell factor (TCF) binding.
Figure 2
Figure 2
Scheme of Wnt lipidation and modifiers. The endoplasmic reticulum (ER)-associated acyltransferase porcupine is essential for Wnt lipidation with palmitoleic acid at S209 or equivalents and probably contributes to C77 palmitoylation. Porcupine is probably assisted by other acyl-CoA transferases (ACTs). Mitochondrial Wnt2B is arrested by ACSL5-dependent palmitoylation and does not further contribute to nuclear Wnt signaling.

Similar articles

Cited by

References

    1. Alexandre C., Baena-Lopez A., Vincent J.-P. Patterning and growth control by membrane-tethered Wingless. Nature. 2014;505:180–185. doi: 10.1038/nature12879. - DOI - PMC - PubMed
    1. Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell. 2013;154:274–284. doi: 10.1016/j.cell.2013.07.004. - DOI - PubMed
    1. Morris S.-A.L., Huang S. Crosstalk of the Wnt/β-catenin pathway with other pathways in cancer cells. Genes Dis. 2016;3:41–47. doi: 10.1016/j.gendis.2015.12.003. - DOI - PMC - PubMed
    1. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 1998;17:1371–1384. doi: 10.1093/emboj/17.5.1371. - DOI - PMC - PubMed
    1. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–1851. doi: 10.1101/cshperspect.a008052. - DOI - PubMed

LinkOut - more resources